Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen.
about
Antigen processing via autophagy--not only for MHC class II presentation anymore?In vivo requirement for Atg5 in antigen presentation by dendritic cells.Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes.Hydrophobicity as a driver of MHC class I antigen processing.Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathwaysUbiquitinated proteins enriched from tumor cells by a ubiquitin binding protein Vx3(A7) as a potent cancer vaccine.Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy.Glycan-regulated antigen processing of a protein in the endoplasmic reticulum can uncover cryptic cytotoxic T cell epitopes.Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins.Autophagy and antigen presentation.Proteasomes, TAP, and endoplasmic reticulum-associated aminopeptidase associated with antigen processing control CD4+ Th cell responses by regulating indirect presentation of MHC class II-restricted cytoplasmic antigensB cells induce tolerance by presenting endogenous peptide-IgG on MHC class II molecules via an IFN-gamma-inducible lysosomal thiol reductase-dependent pathwayAutophagy in CD4+ T-cell immunity and tolerance.Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways.Escape of human cytomegalovirus from HLA-DR-restricted CD4(+) T-cell response is mediated by repression of gamma interferon-induced class II transactivator expressionDetection and quantification of CD4(+) T cells with specificity for a new major histocompatibility complex class II-restricted influenza A virus matrix protein epitope in peripheral blood of influenza patients.Multi-epitope DNA vaccines.Sculpting MHC class II-restricted self and non-self peptidome by the class I Ag-processing machinery and its impact on Th-cell responses.Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma.
P2860
Q27687223-CF010BA3-BE25-49B2-ADC0-230584F0C620Q34376166-44E69732-F515-4707-ADAD-9B21FE0FE579Q34593324-CAC5FFC3-B383-4D41-8385-95FB2CC654B0Q35007960-E0856CAF-BF51-42BB-A209-8A6533A17FFDQ35076771-A698FD94-F194-4B3F-93C7-B84AA61BA2DAQ35519862-1AC3D97F-45D5-4A2A-8E9F-8FD058F573FDQ36391595-2EDC0D9E-E199-4D32-8327-397BFAB67C3DQ36404091-E2B04194-ED1E-4E38-9BDC-DD17659BFEE6Q36404353-480159E5-5186-4B42-A4C8-7F9B6AA3BF4FQ36471836-E53B3ACE-4A74-4541-9BD2-C3A10AE765A7Q36509997-9D7BFEC9-C582-41E8-9456-7E25D1E41A20Q36983280-5009B838-AB4B-4CC0-BEDA-17A24A716C44Q37219526-EE7EA7B2-C72C-437A-894B-9D202D3E6F8EQ37958695-346BD01F-89D7-4876-905A-88E67EC95CCDQ39595303-6C879D5D-9B0D-4405-AE1A-A1B3C8C84C1AQ39612413-E22574A6-0F88-4BC8-B212-8D02539A7068Q41604754-00DC6D8C-4B9B-447F-BB0B-CE5461F2FEFCQ41966343-D5B4A82C-AA29-4636-937A-A6A6595AD482Q45867029-D501E68C-350D-4600-84FF-F2D5E79E5D33
P2860
Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Presentation of a cytosolic an ...... ong-lived form of the antigen.
@en
Presentation of a cytosolic an ...... ong-lived form of the antigen.
@nl
type
label
Presentation of a cytosolic an ...... ong-lived form of the antigen.
@en
Presentation of a cytosolic an ...... ong-lived form of the antigen.
@nl
prefLabel
Presentation of a cytosolic an ...... ong-lived form of the antigen.
@en
Presentation of a cytosolic an ...... ong-lived form of the antigen.
@nl
P2860
P356
P1476
Presentation of a cytosolic an ...... ong-lived form of the antigen.
@en
P2093
P2860
P304
14692-14697
P356
10.1073/PNAS.93.25.14692
P407
P577
1996-12-01T00:00:00Z